Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 54

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)

Mitchell Smith, MD PhD, Opeyemi Jegede, PhD, Samir Parekh, MD, Curtis A. Hanson, MD, Peter Martin, FRCPC, MD MS, Brian G. Till, MD, Michael Crump, MD FRCPC, John P. Leonard, MD, Jonathan W. Friedberg, MD, Brad S. Kahl, MD, Thomas E. Witzig, MD

Blood (2019) 134 (Supplement_1): 751.

https://doi.org/10.1182/blood-2019-129323

Published: 2019

Journal Articles

Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome

Janna Radtchenko, Daniel Lyons, Yvonne Barnes, Scott Milligan, Edward Drea, PharmD

Blood (2019) 134 (Supplement_1): 2203.

https://doi.org/10.1182/blood-2019-124319

Published: 2019

Journal Articles

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

Blood (2019) 134 (Supplement_1): 2691.

https://doi.org/10.1182/blood-2019-124529

Published: 2019

Journal Articles

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Julie Jaffray, MD, Robert F. Sidonio, Jr., MD MSc, Jemily Malvar, MS, Janice M Staber, MD, Kristina M. Haley, DO, Amy Stillings, Angela C. Weyand, MD, Sarah H. O'Brien, MD, Peter A. Kouides, MD

Blood (2019) 134 (Supplement_1): 628.

https://doi.org/10.1182/blood-2019-122379

Published: 2019

Journal Articles

Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial

Gregory A. Abel, MDMPH, Hajime Uno, PhD, Anna M. Tanasijevic, MPH, Zilu Zhang, MS, Tammy T Hshieh, MD MPH, Clark T Dumontier, MD, Richard Chen, BA, Lee Mozessohn, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Jane Driver, MD MPH

Blood (2019) 134 (Supplement_1): 67.

https://doi.org/10.1182/blood-2019-126158

Published: 2019

Journal Articles

Real-World Use of Emicizumab in Patients with Hemophilia with and without Inhibitors

Isabella McCary, BS, Christine Guelcher, PPCNP-BC, Jan Kuhn, BA, BSN, MSN, Regina Butler, RN-BC, Gita Massey, Michael F. Guerrera, MD, Lance Ballester, MS, Leslie J. Raffini, MD

Blood (2019) 134 (Supplement_1): 1137.

https://doi.org/10.1182/blood-2019-122569

Published: 2019

Journal Articles

High Sensitivity NGS Analysis of MRD in CLL Patients Prospectively Treated with Ibrutinib Plus FCR (iFCR)

Alexander R. Vartanov, MD, Stacey M. Fernandes, BS, Winnie I Nguy, Danielle M. Brander, MD, Svitlana Tyekucheva, PhD, Alexandra Savell, BS, Allison P. Jacob, Jon E. Arnason, MD, Jeremy S. Abramson, MD MMSc, Matthew S. Davids, MD, Jennifer R. Brown, MD PhD

Blood (2019) 134 (Supplement_1): 4291.

https://doi.org/10.1182/blood-2019-124305

Published: 2019

Journal Articles

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Mark Hatfield, PhD, Neel Shah, BPharm, PhD, Tatiana Lawrence, MD, Ahuva Hanau, BS, Alex Lonshteyn, PhD, Derek Weycker, PhD

Blood (2019) 134 (Supplement_1): 4668.

https://doi.org/10.1182/blood-2019-123999

Published: 2019

Journal Articles

Prevalence and Burden of Major Bleeding Events in Patients with Von Willebrand Disease Based on Claims Data from the USA

Mei Lu, MD MSc, Abiola Oladapo, PhD MSc, BPharm, Yanyu Wu, BA, MS, PhD, Sepehr Farahbakhshian, BSc, MSc, Bruce Ewenstein, MD PhD

Blood (2018) 132 (Supplement 1): 2222.

https://doi.org/10.1182/blood-2018-99-113293

Published: 2018

Journal Articles

Home Based Primary Care for Patients with Sickle Cell Disease

Mikaela D Moore, BS, Andrew Schamess, MD, Nita Williams, BS, Ying Huang, MA, MS, Gifty Menka, RN, Payal C Desai, MD

Blood (2018) 132 (Supplement 1): 4721.

https://doi.org/10.1182/blood-2018-99-120040

Published: 2018

Journal Articles

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Woo Jae Kwoun, MD, Jeong-Yeal Ahn, MD, Ja Young Seo, MD, Jae Hoon Lee, MD PhD, Hawk Kim, MD PhD, Jinny Park, MD PhD, Kwai Han Yoo, MD, Sung-Ran Cho, MD, Hye Ryoun Kim, MD

Blood (2018) 132 (Supplement 1): 4947.

https://doi.org/10.1182/blood-2018-99-111468

Published: 2018

Journal Articles

Addressing Challenges in Chronic Lymphocytic Leukemia with Continuing Education: Impact on Practice Behaviors and Knowledge

Anne C Roc, PhD, Julie M. Vose, MD MBA, Susan M. O'Brien, MD, Wendy Turell, DrPH

Blood (2018) 132 (Supplement 1): 5851.

https://doi.org/10.1182/blood-2018-99-120174

Published: 2018

Journal Articles

Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative

Elizabeth Stenger, MD, Allistair Abraham, MD, Curtis D Travers, MPH, Hemalatha G. Rangarajan, MD, Diane Hsu, MD, Sonali Chaudhury, MBBS,MD, Kimberly A. Kasow, DO, Michael J. Eckrich, MD MPH, Alexander I. Ngwube, MD, Julie Kanter, MD, Gregory M Guilcher, MDBSc,FRCPC, John T. Horan, MDMPH, Lakshmanan Krishnamurti, MD, Shalini Shenoy, MD

Blood (2017) 130 (Supplement 1): 3271.

https://doi.org/10.1182/blood.V130.Suppl_1.3271.3271

Published: 2017

Journal Articles

Addressing Challenges in Chronic Phase Chronic Myeloid Leukemia: Impact of Education on Practice Behaviors and Knowledge

Anne Roc, PhD, Wendy Turrell, DrPH, David P. Steensma, MD

Blood (2017) 130 (Supplement 1): 5616.

https://doi.org/10.1182/blood.V130.Suppl_1.5616.5616

Published: 2017

Journal Articles

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Elizabeth Stenger, MD, Kirshma Khemani, MD, Diana Ross, MSN, RN, Lillian Meacham, MD, Courtney McCracken, PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD

Blood (2017) 130 (Supplement 1): 1999.

https://doi.org/10.1182/blood.V130.Suppl_1.1999.1999

Published: 2017

Journal Articles

Cold and Mechanical Hypersensitivity Is Exacerbated during Acute Pain in Children and Adolescents with Sickle Cell Disease

Amanda M Brandow, DO, MS, Karla Hansen, Melodee Nugent, Amy Pan, Julie Panepinto

Blood (2017) 130 (Supplement 1): 2259.

https://doi.org/10.1182/blood.V130.Suppl_1.2259.2259

Published: 2017

Journal Articles

Deferasirox Adherence and Persistence Among Texas Medicaid Patients Taking Dispersible Tablets and Film-Coated Tablets

Kristin Richards, PhD, Kenneth A Lawson, PhD, Qayyim Said, PhD, Rahul Sasane, PhD

Blood (2017) 130 (Supplement 1): 4723.

https://doi.org/10.1182/blood.V130.Suppl_1.4723.4723

Published: 2017

Journal Articles

PDX Models Recapitulate Genetics and Epigenetics of Pediatric T-Cell Leukemia

Blood (2017) 130 (Supplement 1): 2723.

https://doi.org/10.1182/blood.V130.Suppl_1.2723.2723

Published: 2017

Journal Articles

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Charlotte Wilding, BSc, MBChB, Farheen Mir, MBBS, Indu Mitra, Bhupinder Sharma, Larissa Sena, Andrew Wotherspoon, David Cunningham, MD FRCP, Ian Chau, MD, Claire E. Dearden, MD FRCP, FRCPath, Kabir Mohammed, Sunil Iyengar

Blood (2017) 130 (Supplement 1): 2786.

https://doi.org/10.1182/blood.V130.Suppl_1.2786.2786

Published: 2017

Journal Articles

Bone Marrow Cellularity and Recovery of Blood Counts after Venetoclax and Azacitidine in Elderly Acute Myeloid Leukemia Patients Unfit for Induction Chemotherapy

James Dugan, MD, Daniel A. Pollyea, MD, Diana Abbott, PhD, Theodore Schultheiss, MD

Blood (2017) 130 (Supplement 1): 5086.

https://doi.org/10.1182/blood.V130.Suppl_1.5086.5086

Published: 2017

NARROW

Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)

Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study

Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial

Real-World Use of Emicizumab in Patients with Hemophilia with and without Inhibitors

High Sensitivity NGS Analysis of MRD in CLL Patients Prospectively Treated with Ibrutinib Plus FCR (iFCR)

Effectiveness of Romiplostim for Treatment of Adults with Newly Diagnosed or Persistent Primary Immune Thrombocytopenia in US Clinical Practice

Prevalence and Burden of Major Bleeding Events in Patients with Von Willebrand Disease Based on Claims Data from the USA

Home Based Primary Care for Patients with Sickle Cell Disease

Evaluation of Clinical Usefulness of Monocyte Gating Using CD14 and CD64 for Detecting PNH Clone By Flow Cytometry

Addressing Challenges in Chronic Lymphocytic Leukemia with Continuing Education: Impact on Practice Behaviors and Knowledge

Development of a Multi-Center Cohort to Evaluate Long-Term Outcomes and Late Effects Following Hematopoietic Cell Transplantation for Sickle Cell Disease: A STAR Initiative

Addressing Challenges in Chronic Phase Chronic Myeloid Leukemia: Impact of Education on Practice Behaviors and Knowledge

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Cold and Mechanical Hypersensitivity Is Exacerbated during Acute Pain in Children and Adolescents with Sickle Cell Disease

Deferasirox Adherence and Persistence Among Texas Medicaid Patients Taking Dispersible Tablets and Film-Coated Tablets

PDX Models Recapitulate Genetics and Epigenetics of Pediatric T-Cell Leukemia

Focal Splenic Lesions May Identify Patients Who Benefit from Anthracycline Based Therapy and Are Significantly Associated with High Grade Transformation in Follicular Lymphoma

Bone Marrow Cellularity and Recovery of Blood Counts after Venetoclax and Azacitidine in Elderly Acute Myeloid Leukemia Patients Unfit for Induction Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only